Bristol-Myers SquibbPublication
Combination Therapies Using PRMT5 Inhibitors and Bcl-2 Family Inhibitors for the Treatment of Cancer.
The filing
Publication US20260355188A1 (opens in a new tab), MIRATI THERAPEUTICS, INC., Nov 12, 2026.
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.